Literature DB >> 20079567

Robotic-assisted laparoscopic intracorporeal urinary diversion.

Raj S Pruthi1, Jeff Nix, Dan McRackan, Adam Hickerson, Matthew E Nielsen, Matthew Raynor, Eric M Wallen.   

Abstract

BACKGROUND: Recent small case series have now been reported for robotic-assisted laparoscopic radical cystectomy (RALRC). In most of these series, the urinary diversion has been performed in an extracorporeal fashion. There have been few case reports of an intracorporeal diversion and little description of the technique of such a procedure.
OBJECTIVE: In this paper, we report our initial experience with robotic-assisted laparoscopic intracorporeal urinary diversion, describing stepwise the surgical procedure itself and evaluating perioperative and pathologic outcomes of this novel procedure. DESIGN, SETTING, AND PARTICIPANTS: We studied a single-institution case series of patients undergoing robotic-assisted cystectomy and intracorporeal urinary diversion for clinically localized urothelial carcinoma of the bladder (n=10) or for a noncompliant dysfunctional bladder refractory to more conservative management (n=2). Historical comparisons are also made to a consecutive case series of 20 patients undergoing robotic radical cystectomy and extracorporeal urinary diversion. SURGICAL PROCEDURE: RALRC and intracorporeal urinary diversion, including ileal conduit (n=9) and orthotopic ileal neobladder (n=3). MEASUREMENTS: The stepwise operative procedure is described in detail. Outcome measures evaluated in this series included operative variables, hospital recovery, and complication rate. Comparisons were made to a contemporaneous series of 20 patients who underwent a robotic cystectomy with extracorporeal diversion during this time period (from an experience of >100 robotic cystectomy patients since 2005). RESULTS AND LIMITATIONS: Twelve patients (mean age: 60.9 yr) underwent an intracorporeal diversion. Mean operating-room time of all patients was 5.3h, and mean surgical blood loss was 221ml. Mean time to flatus, bowel movement, and hospital discharge was 2.2 d, 3.2 d, and 4.5 d, respectively. Eleven of the 12 patients were discharged on or before postoperative day 5. There were six postoperative complications in five patients (42%), with one complication being Clavien grade 3 or higher. The major limitations of the study are the small sample size and the nonrandomized nature of the compared treatment groups (intracorporeal vs extracorporeal), which limits the ability to directly compare the techniques at a high level of scientific confidence.
CONCLUSIONS: Our initial experience with robotic-assisted laparoscopic intracorporeal diversion appears to be favorable with acceptable operative and short-term clinical outcomes.
Copyright © 2010 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20079567     DOI: 10.1016/j.eururo.2009.12.028

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  32 in total

Review 1.  Current status and outcomes of robot-assisted laparoscopic radical cystectomy and urinary diversion.

Authors:  Kyle A Richards; Ashok K Hemal
Journal:  Curr Urol Rep       Date:  2011-04       Impact factor: 3.092

Review 2.  The Role of Robotics in the Invasive Management of Bladder Cancer.

Authors:  Pramit Khetrapal; Wei Shen Tan; Benjamin Lamb; Melanie Tan; Hilary Baker; James Thompson; Ashwin Sridhar; John D Kelly; Tim Briggs
Journal:  Curr Urol Rep       Date:  2017-08       Impact factor: 3.092

3.  Canada's first robotic-assisted totally intracorporeal orthotopic ileal neobladder.

Authors:  Richard L Haddad; Patrick Richard; Franck Bladou
Journal:  Can Urol Assoc J       Date:  2013 Jul-Aug       Impact factor: 1.862

4.  [First line therapy for local advanced or metastatic urothelial cell carcinoma: randomized phase II study to investigate the combination of vinflunine with gemcitabine and vinflunine with carboplatin in patients unfit for cisplatin therapy with advanced or metastatic urothelial cell carcinoma (JASINT-1 - AB 38/11) of AUO].

Authors:  H Rexer
Journal:  Urologe A       Date:  2011-08       Impact factor: 0.639

5.  Robotic Intracorporeal Continent Cutaneous Urinary Diversion: Primary Description.

Authors:  Alvin C Goh; Monty A Aghazadeh; Ross E Krasnow; Alexander W Pastuszak; Julie N Stewart; Brian J Miles
Journal:  J Endourol       Date:  2015-02-05       Impact factor: 2.942

6.  A "pickup" stereoscopic camera with visual-motor aligned control for the da Vinci surgical system: a preliminary study.

Authors:  Apeksha Avinash; Alaa Eldin Abdelaal; Prateek Mathur; Septimiu E Salcudean
Journal:  Int J Comput Assist Radiol Surg       Date:  2019-05-06       Impact factor: 2.924

7.  Does steep Trendelenburg positioning effect the ocular hemodynamics and intraocular pressure in patients undergoing robotic cystectomy and robotic prostatectomy?

Authors:  Muhammet Fuat Ozcan; Ziya Akbulut; Canan Gurdal; Sinan Tan; Yelda Yildiz; Serdar Bayraktar; Ayse Nur Ozcan; Kemal Ener; Serkan Altinova; Muhammed Ersagun Arslan; Mevlana Derya Balbay
Journal:  Int Urol Nephrol       Date:  2016-11-01       Impact factor: 2.370

Review 8.  Current status of robot-assisted radical cystectomy for bladder cancer.

Authors:  Faris Azzouni
Journal:  Nat Rev Urol       Date:  2012-07-31       Impact factor: 14.432

9.  Robotic assisted laparoscopic radical cystectomy with stentless intracorporeal modified Ves.Pa neobladder: early experience.

Authors:  Patrick Whelan; Wei Phin Tan; Dimitri Papagiannopoulos; Philip Omotosho; Leslie Deane
Journal:  J Robot Surg       Date:  2017-01-09

Review 10.  Updates on Robotic Intracorporeal Urinary Diversions.

Authors:  Shawn Dason; Alvin C Goh
Journal:  Curr Urol Rep       Date:  2018-03-15       Impact factor: 3.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.